Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Christopher Rajkumar MBBS, BSc, MRCP

Christopher A. Rajkumar MBBS, BSc, MRCP

Clinical Research Training Fellow, Interventional Cardiology, Imperial College London, London, United Kingdom

Dr. Christopher Rajkumar is a Medical Research Council funded Clinical Research Training Fellow in interventional cardiology at Imperial College London. His research is focussed upon the symptomatic response to revascularisation in stable coronary artery disease.

He was the first author of the randomised, placebo-controlled ORBITA-2 Trial which was published in the New England Journal of Medicine in 2023. He has also conducted the n-of-1 ORBITA-STAR clinical study, which seeks to identify predictors of response to revascularisation.

Dr. Rajkumar trained at Imperial College London and was subsequently awarded competitive academic foundation and academic clinical fellowship appointments in the North-West London training rotation before being awarded his PhD fellowship. He was recently awarded the Royal Society of Medicine’s gold medal President’s Prize for his PhD research.


Dr. Rajkumar disclosures Speaker’s fees for Menarini pharmaceutials and consultancy fees for Philips.

Recent Contributions to PracticeUpdate:

  1. Effect of PCI in Patients With Stable Angina